Cargando…
Biology of the mRNA Splicing Machinery and Its Dysregulation in Cancer Providing Therapeutic Opportunities
Dysregulation of messenger RNA (mRNA) processing—in particular mRNA splicing—is a hallmark of cancer. Compared to normal cells, cancer cells frequently present aberrant mRNA splicing, which promotes cancer progression and treatment resistance. This hallmark provides opportunities for developing new...
Autores principales: | Blijlevens, Maxime, Li, Jing, van Beusechem, Victor W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8150589/ https://www.ncbi.nlm.nih.gov/pubmed/34065983 http://dx.doi.org/10.3390/ijms22105110 |
Ejemplares similares
-
Silencing Core Spliceosome Sm Gene Expression Induces a Cytotoxic Splicing Switch in the Proteasome Subunit Beta 3 mRNA in Non-Small Cell Lung Cancer Cells
por: Blijlevens, Maxime, et al.
Publicado: (2020) -
A genome‐wide siRNA screen for regulators of tumor suppressor p53 activity in human non‐small cell lung cancer cells identifies components of the RNA splicing machinery as targets for anticancer treatment
por: Siebring‐van Olst, Ellen, et al.
Publicado: (2017) -
Dysregulation of the splicing machinery is directly associated to aggressiveness of prostate cancer
por: Jiménez-Vacas, Juan M., et al.
Publicado: (2020) -
Targeting pre-mRNA splicing in cancers: roles, inhibitors, and therapeutic opportunities
por: Araki, Shinsuke, et al.
Publicado: (2023) -
Oncogenic dysregulation of pre‐mRNA processing by protein kinases: challenges and therapeutic opportunities
por: Naro, Chiara, et al.
Publicado: (2021)